ASTS
AST SpaceMobile, Inc.
ASTS lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to grow, though they disagree widely on how much.
MYSZ
My Size, Inc.
There isn't enough reported data to score MYSZ yet.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
MYSZ Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
MYSZ's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
MYSZ PE Valuation
MYSZ has no meaningful PE right now: it lost money over the past year.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
MYSZ Forward outlook
There aren't enough analyst estimates for MYSZ to show an outlook.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
ASTS is still losing money, but far less than before: $2.15 per share over the past year, against $5.76 at its worst in mid-2021.
MYSZ Earnings Per Share
MYSZ and ASTS do not have enough comparable growth data to identify a winner.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS has the edge over MYSZ on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was −415% last quarter, up 694 points from the same quarter a year ago.
MYSZ Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $3.1M | +53% |
| Q1 2026 | $2.4M | +62% |
| Q4 2025 | $3.3M | +127% |
| Q3 2025 | $2.6M | +40% |
| Q2 2025 | $2M | +1.4% |
| Q1 2025 | $1.5M | -50% |
| Q4 2024 | $1.5M | -49% |
| Q3 2024 | $1.8M | -15% |
MYSZ's revenue has grown year over year for five quarters in a row: $3M last quarter, up 53% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -56% | -27 points |
| Q1 2026 | -59% | +13 points |
| Q4 2025 | -83% | -35 points |
| Q3 2025 | -53% | +18 points |
| Q2 2025 | -29% | +15 points |
| Q1 2025 | -72% | -36 points |
| Q4 2024 | -47% | +8.8 points |
| Q3 2024 | -71% | -20 points |
MYSZ has the edge over ASTS on profitability, with a higher operating margin.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
MYSZ has the stronger cash trend. Its trailing FCF is up 18% versus its history, compared with ASTS at down 363%.
MYSZ Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q1 2026 | -$2.1M | -$847K |
| Q3 2025 | -$500K | -$53K |
| Q1 2025 | -$1.3M | +$149K |
| Q4 2022 | -$1.4M | +$1.9M |
| Q3 2022 | -$1.8M | -$475K |
| Q2 2022 | -$1.5M | -$88K |
| Q1 2022 | -$2.6M | -$1.3M |
| Q4 2021 | -$3.3M | -$1.4M |
MYSZ has burned cash in almost every quarter: −$5M over the past year, against −$4M the year before.
ASTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +1.1M shares |
| 1 year | +10% | +27.3M shares |
| 3 years | +235% | +211M shares |
| 5 years | +480% | +248M shares |
| Available history | +944% | +271M shares |
ASTS has the edge over MYSZ on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
MYSZ Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +1.7K shares |
| 1 year | +129% | +339K shares |
| 3 years | +3674% | +585K shares |
| 5 years | +48138% | +599K shares |
MYSZ has 600,560 diluted shares, up 129% from a year ago.
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
MYSZ Net Leverage
MYSZ's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
MYSZ Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 21.2 | Oversold |
| Stochastic | 1.7 | Oversold |
MYSZ's weekly RSI is 21 (oversold) and its Stochastic is 2 (oversold).
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
MYSZ PE vs Technology Sector
MYSZ has no meaningful PE right now: it lost money over the past year.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has the edge over MYSZ on trend strength, trading above more of its moving averages.
MYSZ Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.16 | 40% below |
| 20 week MA | $2.17 | 68% below |
| 50 week MA | $4.01 | 83% below |
| 100 week MA | $8.37 | 92% below |
| 200 week MA | $29.8 | 98% below |
MYSZ is in a downtrend: it's below all five of its weekly moving averages, and 98% below its 200-week average.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS has the edge over MYSZ on returns for 2026, with the stronger performance.
MYSZ Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5,376.0 | $2,000.0 | -63% |
| 2021 | $2,000.0 | $1,036.8 | -48% |
| 2022 | $1,036.8 | $167.0 | -84% |
| 2023 | $167.0 | $43.2 | -74% |
| 2024 | $43.2 | $52.1 | +21% |
| 2025 | $52.1 | $6.58 | -87% |
| 2026 YTD | $6.58 | $0.70 | -89% |
MYSZ has finished lower in five of the last six years. It's down 89% so far in 2026.